I compared and studied Celgene placenta treatment for 2 weeks.
Celgene made lots of mistakes, but none big enough they can't afford
In the same time, somebody will have to answer why their bio division is over 100 people, over budget and underperformed.
They are so much behind PSTI, I wouldn't even call them competition.
And yes, when they decided to use the Fetal-side of the placenta, may not be the appropriate phrasing but they screwed the pooch from the beginning.
Yes they did. They are effectivly out of the game. But they will not let themselves be shut out. Their very survival depends on getting into stem cell space at the right time.
WHEN that right time arrives, they will buy their way in. They have no choice. I'm not going to speculate who they will buy. But they will HAVE to get into this branch of health and there is only one way for them.